Adenocarcinoma
Adenocarcinoma
Adenocarcinoma
Neuroendocrine
Neuroendocrine
Adenocarcinoma
|
CTC
Metastatic lesion
CTC
PDX
Prostatectomy & metastatic lesion
PDX
PDX
Metastatic lesion
Primary tumor
|
1
N/A
6
11
3
1
4
1
|
15%
16% (4/25)
N/A
|
N/A
7 days
7 days
More than 10
5
|
N/A
74 anticancer compounds
17 anticancer compounds
Anti-B7-H3 ADC
Anti-B7-H3 ADC
EZH2 inhibitor
129 anticancer compounds
EZH2 inhibitor
DRD2 antagonist
|
[73]
[74]
[75]
[49]
[44]
|